Learn more about whether Mesa Laboratories, Inc. is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how (MLAB) grades on certain investment factors and determine whether it meets your investment needs.

Latest Mesa Laboratories, Inc. Stock News

As of September 04, 2026, Mesa Laboratories, Inc. had a $715.0 million market capitalization, putting it in the 40th percentile of companies in the Life Sciences Tools & Services industry.

Currently, Mesa Laboratories, Inc.’s price-earnings ratio is 148.4. Mesa Laboratories, Inc.’s trailing 12-month revenue is $249.7 million with a 1.9% profit margin. Year-over-year quarterly sales growth most recently was 1.0%. Analysts expect adjusted earnings to reach $9.950 per share for the current fiscal year. Mesa Laboratories, Inc. currently has a 0.5% dividend yield.



Sign Up to Receive a Free Special Report That Shows How A+ Investor Grades Can Help You Make Investment Decisions

Grading Mesa Laboratories, Inc. Stock

Before you choose to buy, sell or hold Mesa Laboratories, Inc. stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement. To help individual investors decide whether or not to buy (MLAB) stock, AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way that is suitable for investors of all knowledge levels.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings revisions and quality. Here, we’ll take a closer look at Mesa Laboratories, Inc.’s stock grades for value, growth and quality. Learn more about A+ Investor here!

Mesa Laboratories, Inc. Stock Value Grade

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade is derived from a stock’s value score. The value score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Mesa Laboratories, Inc. has a Value Score of 22, which is Expensive.

Mesa Laboratories, Inc. Stock Growth Grade

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the Growth Score and assign it a letter grade, the percentile ranks for each of the three individual components‐consistency of annual sales growth, five‐year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered Very Weak, while those in the top 20% receive A grades, which are considered Very Strong.

Mesa Laboratories, Inc. has a Growth Score of 83, which is Very Strong.

Don’t Miss Your Free Report — Sign Up Here!

Mesa Laboratories, Inc. Stock Momentum Grade

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Mesa Laboratories, Inc. has a Momentum Score of 86, which is Very Strong.

Other Mesa Laboratories, Inc. Stock Grades

In addition to Value, Momentum and Growth, A+ Investor also provides grades for Estimate Revisions and Quality.

The Earnings Estimate Revisions Grade takes into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too). AAII’s stock screen that follows the companies with the highest earnings estimate revisions (i.e., the best grades) has a 23.3% backtested annual return since inception, whereas an example screen following those with the worst revisions has a backtested annual return since inception of under 5%.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the Quality Grade is the percentile rank of the composite return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F—Score.

These 2 key factors, when combined with the above, provide a holistic view into a stock. Further, by joining A+ Investor you can see whether Mesa Laboratories, Inc.’s stock passes any of our 60+ stock screens that have outperformed the market since their creation.

Should I Buy Mesa Laboratories, Inc. Stock?

Overall, Mesa Laboratories, Inc. stock has a Value Grade of D, Growth Grade of A, and Momentum Grade of A.

Whether or not you should buy Mesa Laboratories, Inc. stock will ultimately depend on your individual goals, risk tolerance and allocation. AAII can help you figure these out and identify which investments align with what works best for you.

Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Mesa Laboratories, Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions.

Mesa Laboratories, Inc. (MLAB) Competitors

Companies similar to Mesa Laboratories, Inc. in the Life Sciences Tools & Services industry.

Company name	Ticker	Market Cap
Ginkgo Bioworks Holdings, Inc.	DNA	$447.16Mil
Cytek Biosciences, Inc.	CTKB	$610.92Mil
OmniAb, Inc.	OABI	$629.54Mil
Evotec SE	EVO	$661.71Mil
Cryoport, Inc.	CYRX	$800.76Mil

Mesa Laboratories, Inc. Stock: Bottom Line

You can use the information about how Mesa Laboratories, Inc. is graded to determine if you should invest in this stock. However, you should decide whether Mesa Laboratories, Inc.’s stock is a buy, sell or hold based on a combination of grades, metrics, ratios and U.S. Securities and Exchange Commission (SEC) reports.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets—without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

So, if you’re still on the fence about whether Mesa Laboratories, Inc. is a buy, sell or hold, you can utilize AAII’s expansive and robust screening tools like A+ Investor to help with your decision.

A+ Investor adds to its qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions, find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.